Trials / Completed
CompletedNCT00231075
Evaluation of the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III-IV
National, Phase II Study Designed to Evaluate the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III and IV. FAG-2
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 75 (planned)
- Sponsor
- ARCAGY/ GINECO GROUP · Academic / Other
- Sex
- Female
- Age
- 70 Years
- Healthy volunteers
- Not accepted
Summary
Safety and Efficacy of Paraplatin in combination with Taxol in patients of 70 years or older with epithelial ovary cancer F.I.G.O. stages III and IV.
Detailed description
The Main objective of this study is to evaluate the faisibility of chemotherapy with Paraplatin in combination with Taxol in patients of 70 years or older with epithelial ovary cancer F.I.G.O. stages III and IV and to determine principal predictive factors of this feasibility.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paraplatin | |
| DRUG | Paclitaxel |
Timeline
- Start date
- 2001-01-01
- Completion
- 2007-05-01
- First posted
- 2005-10-04
- Last updated
- 2005-11-03
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT00231075. Inclusion in this directory is not an endorsement.